D-1047-2020 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-1047-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 9, 2020 and is designated Class II. Reason for recall: Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg. The recall status is terminated (terminated Feb 9, 2021). Affected quantity: 1416 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Mar 9, 2020
Termination Date
Feb 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1416 bottles

Product description

Atorvastatin Calcium Tablets, USP 40 mg, Rx only, 500-count bottle, Manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-829-05

Reason for recall

Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Distribution pattern

U.S.A. Nationwide

Code information

Lot#: AA33617, Exp 03/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1047-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1047-2020. Report a data issue: hello@regdatalab.com.